Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Impact Map
Manufacturing Partnerships
Our Science
Pipeline
Publications
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
All Publications
Filter:
Program
Medical Countermeasures
Opioid Antagonist
Filter
May 16, 2020
Current Status and Trends in Prophylaxis and Management of Anthrax Disease
Read More
April 3, 2020
Organic and Inorganic Nanoparticle Vaccines for Prevention of Infectious Diseases
Read More
February 8, 2020
Development of a Guinea Pig Inhalational Anthrax Model for Evaluation of Post-Exposure Prophylaxis Efficacy of Anthrax Vaccines
Read More
September 25, 2019
GC-072: A Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens
Read More
September 19, 2019
Comparative Immunogenicity and Efficacy of Thermostable (Lyophilized) and Liquid Formulation of Anthrax Vaccine Candidate AV7909
Read More
June 11, 2019
Repeat-Dose Toxicity Study of a Lyophilized Recombinant Protective Antigen-Based Anthrax Vaccine Adjuvanted With CpG 7909
Read More
August 5, 2017
Correlation Between Anthrax Lethal Toxin Neutralizing Antibody Levels and Survival in Guinea Pigs and Nonhuman Primates Vaccinated with the AV7909 Anthrax Vaccine Candidate
Read More
October 30, 2016
Licensure Strategy for Pre- and Post-Exposure Prophylaxis of Biothrax Vaccine: The First Vaccine Licensed Using the FDA Animal Rule
Read More
May 6, 2016
Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose
Read More
March 17, 2016
Randomized, Double-Blind, Active-Controlled Study Evaluating the Safety and Immunogenicity of Three Vaccination Schedules and Two Dose Levels of AV7909 Vaccine for Anthrax Post-Exposure Prophylaxis in Healthy Adults
Read More
February 18, 2014
Enhanced Early Innate and T Cell-Mediated Responses in Subjects Immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909)
Read More
August 28, 2013
Evaluation of Intravenous Anthrax Immune Globulin for Treatment of Inhalation Anthrax
Read More
1
2
3
4
